Celanese at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Celanese brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Celanese's program centres on polymers for controlled drug release. Its work covers multilayer ethylene vinyl acetate implants that release the antibody trastuzumab over a long period, and tunable poly(orthoester) injectables for both short and long-acting delivery.

OrganizationAAPS 2026 PharmSci 360 Attendance
Celanese
Irving, TX
Excipients & ingredients
Chemical and specialty materials company whose medical-grade polymers, such as ethylene vinyl acetate, are used in controlled-release drug delivery implants.
Poster
Mon Oct 26
10:30am–11:30am
Long Acting Controlled Delivery of Trastuzumab Via Multilayer VitalDose® EVA Solid Implants
Solution Center · Poster M1030-03-13
Formulation and Delivery - Biomolecular
Poster
Tue Oct 27
2:30pm–3:30pm
Tunable Poly(Orthoester) (POE) Injectable Platforms for Controlled Short- and Long-Acting Drug Delivery
Solution Center · Poster T1430-01-01
Formulation and Delivery - Chemical

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Celanese

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction